Daré Bioscience's Q4 2024 earnings highlight a dual-path strategy for Sildenafil Cream, targeting 2025 revenue with 503B compounding while advancing ...

Q4 2024 Earnings Call Transcript March 31, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, ...

With increasing demand for needed treatments designed for women, Daré is taking action to make its proprietary Sildenafil ...

The company projects initial revenue generation from its Sildenafil Cream formulation in Q4 2025, backed by its 503B compounding strategy. Daré plans to provide updates in Q2 2025 on strategic ...

Experts warn that ExtenZe may not be safe to use for erectile dysfunction. Read on to find out why and to learn about its ...

Welcome to the conference call hosted by Dare Bioscience to review the company's 2024 financial results and to provide a business update. This call is being recorded. My name is Jericho, and I'll be ...

The Food and Drug Administration (FDA) has cautioned those taking a libido-boosting herbal dietary supplement after an ...

Viagra is a safe and effective treatment for ED. But as the saying goes, you can have too much of a good thing — and Viagra ...

Viagra was approved by the U.S. Food and Drug Administration 27 years ago. Experts say it immediately changed the way we talk ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

Shane Warne passed away in March 2022, and after three years, some shocking details have grabbed the attention out of nowhere ...